PharmaVoice 100
-
PharmaVoice 100
2024 PharmaVoice 100s: Cancer Care Visionaries
Leaders who envision a world without cancer through oncology innovation.
By Michael Gibney • Nov. 1, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Clinical Trial Pros
Experts raising the bar in clinical trial design and collaboration.
By Amy Baxter • Oct. 31, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers
Leaders molding the cutting-edge cell and gene therapy field into tomorrow's cures.
By Michael Gibney • Oct. 30, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Rare Disease Warriors
Pharma pros driving drug development and access for patients with high unmet needs.
By Meagan Parrish • Oct. 29, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Tech and AI Wizards
Digital pioneers harnessing the data to improve pharma’s outcomes.
By Amy Baxter • Oct. 28, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Biotech Pathfinders
Leaders solving biology's toughest puzzles and driving innovation forward.
By Michael Gibney • Oct. 23, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Patient Champions
Leaders advancing health advocacy, DEI initiatives and better medicine access for patients.
By Meagan Parrish • Oct. 22, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Cardiometabolic All-Stars
Leaders tackling long-standing health needs with new solutions.
By Amy Baxter • Oct. 18, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Trailblazers
Industry leaders charting new paths in science and business.
By Meagan Parrish • Oct. 16, 2024 -
PharmaVoice 100
2024 PharmaVoice 100s: Standout Leaders
Long-time executives with a strong track record of advancing drug R&D, business savvy strategies and leadership in various sectors of pharma.
By Meagan Parrish • Oct. 14, 2024 -
Deep Dive // PharmaVoice 100
The 2024 PharmaVoice 100
This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.
By Julia Himmel • Oct. 8, 2024 -
Q&A
How pharma’s surging M&A is impacting the industry’s tech sector
As dealmaking in biopharma picks up, the CEO of eClinical Solutions sees an opportunity for clinical software companies to make acquisitions easier to close.
By Michael Gibney • April 11, 2024 -
10 of our most read articles in 2023
A presidential candidate, a changing biotech market and an enduring murder mystery — here are PharmaVoice’s most-read articles this year.
By Meagan Parrish • Dec. 22, 2023 -
PharmaVoice 100
PharmaVoice 100s: Entrepreneurs
From biotech startups to a services agency, these entrepreneurs are hedging their bets to offer innovative approaches in patient care.
By Meagan Parrish • Nov. 3, 2023 -
Q&A // Red Jacket winners 2023
Red Jacket: Dr. Mark Goldberg, a clinical innovator
Dr. Mark Goldberg has continually been at the cutting edge of technologies and ideas, including now as chairman and CEO of Allucent.
By Alexandra Pecci • Oct. 27, 2023 -
Q&A // Red Jacket winners 2023
Red Jacket: Ken Getz, a champion of clinical trials
Ken Getz has spent his career improving clinical research for the benefit of patients, the life sciences industry and other R&D stakeholders.
By Alexandra Pecci • Oct. 27, 2023 -
Q&A // Red Jacket winners 2023
Red Jacket: Dr. Jeremy Levin, a transformational leader
A consummate life sciences executive who has led with boldness and devotion, Dr. Jeremy Levin considers himself a participant as well as a leader.
By Michael Gibney • Oct. 27, 2023 -
The 2023 Red Jacket honorees
This year's inductees to the PharmaVoice 100 "hall of fame" are leaders who have been at the forefront — and will stay at the forefront — of industry change.
By Meagan Parrish • Oct. 27, 2023 -
Q&A // Red Jacket winners 2023
Red Jacket: Helen Sabzevari, an immunotherapy pioneer
Precigen’s CEO is pushing for her next therapeutic breakthrough with innovative cell and gene therapy platforms.
By Meagan Parrish • Oct. 27, 2023 -
Q&A // Red Jacket winners 2023
Red Jacket: Adele Gulfo, a commercialization guru
With a knack for melding science and patient-focused marketing techniques, the CEO of the biopharma commercial unit at Sumitomo Pharma America has notched blockbuster successes throughout her career.
By Karissa Waddick • Oct. 27, 2023 -
PharmaVoice 100
PharmaVoice 100s: Clinical trial gurus
Industry leaders adopting cutting-edge technologies and strategies to change the paradigm of clinical research.
By Meagan Parrish • Oct. 19, 2023 -
PharmaVoice 100
PharmaVoice 100s: Rare disease warriors
Biopharma leaders pounding away at rare diseases so patients with few other options can have healthier lives.
By Michael Gibney • Oct. 16, 2023 -
Opinion
Branded: The trademarks pharma leaders look up to
What do brands like Patagonia, Nike and Lego have to do with pharma? Here are some of the brands industry leaders relate to most — and how they inspire work in the life sciences.
By PharmaVoice Staff • Oct. 13, 2023 -
Q&A
5 minutes with — IDEA Pharma’s Mike Rea
The CEO on the secrets of innovative pharma companies, his record collection and what he’d always rather be doing.
By Meagan Parrish • Oct. 11, 2023 -
PharmaVoice 100
PharmaVoice 100s: Brand and commercialization pros
Leaders decoding the complex language of drug development to push treatments past the finish line and into patients’ hands.
By Karissa Waddick • Oct. 4, 2023